Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women

A combination of clinical characteristics and first-trimester maternal serum biomarkers (pregnancy-associated plasma protein-A, Inhibin-A, and placental growth factor) provides an accurate screening for early-onset preeclampsia in nulliparous women.